Vontobel Financial Products GmbH Stock

Certificat

DE000VD2W696

Market Closed - Börse Stuttgart 02:12:24 2024-06-06 am EDT
101.4 EUR -0.28% Intraday chart for Vontobel Financial Products GmbH
Current month+3.06%
1 month+2.81%
Date Price Change
24-06-06 101.4 -0.28%
24-06-05 101.6 +0.43%
24-06-04 101.2 +1.74%
24-06-03 99.48 +1.14%
24-05-31 98.36 +0.56%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 02:12 am EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD2W69
ISINDE000VD2W696
Date issued 2024-03-27
Strike 34.15 $
Maturity 2025-03-27 (294 Days)
Parity 0.03 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 102.4
Lowest since issue 92.78

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.8 USD
Average target price
31.92 USD
Spread / Average Target
+10.82%
Consensus